Medtecs International Corporation Ltd.

Medtecs International Corporation Ltd.

4.96
TWD
+0.01
(+0.20%)
1.44BMarket Cap
Mar 01Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.25
0.23
0.25
0.21
0.22
0.24
0.25
1.43
0.52
0.2
0.19
0.2
0.28
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
0.47
0.06
-0.1
-0.08
-0.08
-0.02
- -
Free Cash Flow per Basic Share
0.02
0.03
0.02
0.01
- -
- -
- -
0.33
0.05
-0.06
-0.05
- -
-0.03
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
0.02
0.08
0.01
- -
- -
- -
- -
Book Value per Share
0.24
0.23
0.21
0.22
0.22
0.22
0.23
0.69
0.67
0.54
0.47
0.38
0.37
0.37
Tangible Book Value per Share
0.24
0.23
0.21
0.21
0.22
0.22
0.22
0.69
0.66
0.54
0.45
0.37
0.36
0.36
Basic Weighted Avg Shares
221
227
247
280
280
280
280
280
278
278
277
277
277
545
Sales/Revenue/Turnover
56
52
62
58
62
68
69
400
144
56
53
54
79
- -
Operating Margin (%)
3.76
2.2
5.07
4.14
3.99
3.84
4.62
34.08
11.59
-57.68
-46.66
-51.53
-7.92
- -
Depreciation Expense
4
4
4
3
5
5
6
8
7
6
7
8
7
- -
Net Income, GAAP
1
- -
1
1
1
1
1
132
17
-29
-21
-22
-5
- -
Effective Tax Rate (%)
32.16
66.76
68.62
34.72
8.59
22.93
23.14
2.5
2.41
- -
- -
- -
- -
- -
Profit Margin (%)
1.1
0.74
0.86
1.77
1.43
1.34
1.68
32.9
12.03
-50.84
-40.02
-41.2
-6.03
- -
Working Capital
22
23
24
25
27
32
34
160
143
85
63
70
33
49
LT Debt
8
4
2
- -
2
6
9
3
6
3
2
2
3
3
Total Equity
57
56
60
62
63
63
65
194
188
152
130
107
102
103
Return on Invested Capital (%)
1.43
0.56
1.08
1.66
2.29
1.99
2.27
77.12
7.44
- -
- -
- -
- -
- -
Return on Capital (%)
1.88
1.02
1.09
2.07
2.3
2.26
2.71
77.91
8.74
- -
- -
- -
- -
- -
Return on Common Equity (%)
1.14
0.7
0.92
1.7
1.44
1.47
1.85
102.48
9.16
-17.07
-15.1
-19.05
-4.59
- -

Capital Structure

USD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
19
18
18
LT Borrowings
- -
- -
- -
LT Finance Leases
2
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
277
277
277
Market Capitalization
48
39
45

Working Capital

USD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
79
73
73
Cash, Cash Equivalents & STI
20
19
23
Accounts Receivable, Net
21
19
14
Inventories
30
28
24
Total Current Liabilities
31
40
24
Payables & Accruals
- -
- -
- -
ST Debt
19
18
18
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.85%
-11.85%
-4.32%
Free Cash Flow
-4,621.18%
77.75%
795.74%
Net Income, GAAP
1,089.43%
-90.07%
-78.75%
Sales/Revenue/Turnover
40.98%
-16.58%
45.1%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
54
2025
- -
- -
79
2026
- -
- -
- -

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.08
2025
- -
- -
-0.02
2026
- -
- -
- -

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Weiyuan Yang
Full Time Employees
3,601
Sector
Health technology
Industry
Medical specialties
Address
No. 9, SongGao Road Taipei TP Taiwan 110
IPO Date
Oct 6, 1999
Business
Medtecs International Corp. Ltd. manufactures and distributes medical consumables for the global healthcare industry. The company offers its products and services in the Asia Pacific. It provides its products in healthcare textiles work wear, medical devises equipment and hospitality textiles. Its products include bed linen, patient gown, scrube suit, blanke, bag-urin bag, rectal tube, endotracheal tube, padiatric urine colletor, apron, napkin, table cloth, waork wear, scrub suit, colored sheets and customart printed sheets. The company was founded in 1989 and is headquartered Taipei, Taiwan.